Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 5;25(22):11878.
doi: 10.3390/ijms252211878.

The Immunomodulatory Role of Regulatory T Cells in Preterm Birth and Associated Pregnancy Outcomes

Affiliations
Review

The Immunomodulatory Role of Regulatory T Cells in Preterm Birth and Associated Pregnancy Outcomes

Nicoleta Mureanu et al. Int J Mol Sci. .

Abstract

Spontaneous preterm birth (sPTB), defined as live birth before 37 weeks of gestational age, is associated with immune dysregulation and pro-inflammatory conditions that profoundly impact newborn health. The question of immune integrity at the maternal-foetal interface is a focus of recent studies centring not only sPTB but the conditions often affiliated with this outcome. Regulatory T cells (Tregs) play a critical anti-inflammatory role in pregnancy, promoting foetal tolerance and placentation. Due to this gestational role, it is hypothesised that decreased or dysfunctional Tregs may be implicated in cases of sPTB. This review examines studies comparing Treg presence in healthy term pregnancies and those with sPTB-associated conditions. Conflicting findings across different conditions and within sPTB itself have been identified. However, notable findings from the research indicate increased proinflammatory cytokines in pregnancies suffering from premature rupture of membranes (pPROM), chorioamnionitis, infection, preeclampsia, and gestational diabetes (GDM). Additionally, reduced Treg levels were identified in preeclampsia, GDM, and pPROM as well as chorioamnionitis presenting with increased Treg dysfunctionality. Treg deficiencies may contribute to health issues in preterm newborns. Current sPTB treatments are limited, underscoring the potential of in utero therapies targeting inflammation, including T cell interventions. Future research aims to establish consensus on the role of Tregs in sPTB and associated conditions and advancing understanding of mechanisms leading to Treg deficiencies in adverse pregnancy outcomes.

Keywords: Tregs; pregnancy immunology; spontaneous preterm birth.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the writing of the manuscript.

Figures

Figure 1
Figure 1
Suppressive mechanisms elicited by Tregs. Tregs can elicit their immunosuppressive functions through various mechanisms. These include the expression of co-inhibitory external markers such as PD-1 or CTLA-4 through cell:cell contact and the production of anti-inflammatory cytokines IL-10 and TGF-β. This allows for the inhibition of the function and maturation of DC and overall immunosuppression of pro-inflammatory effector T cells (Teffs). This image was created in BioRender, adapted from Kempkes, R. W. M., Joosten, I., Koenen, H. J. P. M., and He, X., 2019 [19].

Similar articles

Cited by

References

    1. Tedesco R.P., Galvão R.B., Guida J.P., Passini-Júnior R., Lajos G.J., Nomura M.L., Rehder P.M., Dias T.Z., Souza R.T., Cecatti J.G., et al. The role of maternal infection in preterm birth: Evidence from the Brazilian Multicentre Study on Preterm Birth (EMIP) Clinics. 2020;75:e1508. doi: 10.6061/clinics/2020/e1508. - DOI - PMC - PubMed
    1. Walani S.R. Global burden of preterm birth. Int. J. Gynecol. Obstet. 2020;150:31–33. doi: 10.1002/ijgo.13195. - DOI - PubMed
    1. Phillips C., Velji Z., Hanly C., Metcalfe A. Risk of recurrent spontaneous preterm birth: A systematic review and meta-analysis. BMJ Open. 2017;7:e015402. doi: 10.1136/bmjopen-2016-015402. - DOI - PMC - PubMed
    1. Green S., Politis M., Rallis K.S., Cortabarria A.S.d.V., Efthymiou A., Mureanu N., Dalrymple K.V., Scottà C., Lombardi G., Tribe R.M., et al. Regulatory T Cells in Pregnancy Adverse Outcomes: A Systematic Review and Meta-Analysis. Front. Immunol. 2021;12:737862. doi: 10.3389/fimmu.2021.737862. - DOI - PMC - PubMed
    1. Hwang Y.M., Wei Q., Piekos S.N., Vemuri B., Molani S., Mease P., Hood L., Hadlock J. Maternal-fetal outcomes in patients with immune mediated inflammatory diseases, with consideration of comorbidities: A retrospective cohort study in a large U.S. healthcare system. medRxiv. 2023 doi: 10.1016/j.eclinm.2024.102435. - DOI - PMC - PubMed

LinkOut - more resources